At ACC.25, Boer highlights treatment gaps in the US for lipid control in a high-risk ASCVD population.
Leandro Boer, MD, PhD
Advertisement
Leandro Boer, MD, PhD, vice president of general medicines at Amgen
Articles by Leandro Boer, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Diabetes Increases Mortality Risk Across All Major Organ Transplants
2
GLP-1 RAs Show Renal, Survival Benefits in Kidney Transplant Recipients With Type 2 Diabetes
3
What Are Some Clinical Pearls in Pediatric Dermatology? With Lisa Swanson, MD
4
How to Counsel Patients About Skincare Safety, Sunscreen Safety, and Product Ingredients
5